Zai Lab Ltd ADR (ZLAB)
31.00 x 2 38.00 x 1
Post-market by (Cboe BZX)
31.84 -0.59 (-1.82%) 04/29/25 [NASDAQ]
31.00 x 2 38.00 x 1
Post-market 31.84 unch (unch) 16:00 ET
for Tue, Apr 29th, 2025
Results
download Want to compare other data? Select Fields| Symbol | ZLAB | RNA | RARE | ||
| Company | Zai Lab Ltd ADR | Avidity Biosciences Inc | Ultragenyx Pharmaceu | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 31.46 | 30.91 | 37.97 | ||
| High | 32.37 | 32.19 | 38.44 | ||
| Low | 31.12 | 30.67 | 37.67 | ||
| Last | 31.84 | 32.16 | 38.07 | ||
| Change | -0.59 | +0.95 | +0.09 | ||
| % Change | -1.82% | +3.06% | +0.24% | ||
| Volume | 1,119,000 | 857,100 | 781,900 | ||
| 20-Day Average Volume | 1,683,965 | 1,733,440 | 1,037,400 | ||
| Previous Close | 32.43 | 31.20 | 37.98 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 31.23 | 27.75 | 35.13 | ||
| 20-Day Raw Stochastic | 52.56% | 99.72% | 91.11% | ||
| 20-Day Relative Strength | 49.42% | 56.77% | 52.38% | ||
| Weighted Alpha | +80.96 | -9.13 | -17.59 | ||
| Today's Opinion | 56% Buy | 40% Sell | 80% Sell | ||
| Previous Opinion | 56% Buy | 48% Sell | 80% Sell | ||
| Last Month's Opinion | 100% Buy | 56% Sell | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.12% since 04/22/25 | +9.20% since 04/22/25 | +6.02% since 04/22/25 | ||
| Low | 31.12 on 04/29/25 | 29.78 on 04/24/25 | 36.15 on 04/23/25 | ||
| High | 34.59 on 04/23/25 | 32.19 on 04/29/25 | 38.90 on 04/28/25 | ||
| 1-Month | |||||
| %Chg | -14.62% since 03/28/25 | +1.77% since 03/28/25 | +0.66% since 03/28/25 | ||
| Low | 24.24 on 04/10/25 | 21.51 on 04/09/25 | 29.59 on 04/09/25 | ||
| High | 38.70 on 04/01/25 | 32.19 on 04/29/25 | 38.90 on 04/28/25 | ||
| 3-Month | |||||
| %Chg | +16.89% since 01/29/25 | +0.75% since 01/29/25 | -10.36% since 01/29/25 | ||
| Low | 24.24 on 04/10/25 | 21.51 on 04/09/25 | 29.59 on 04/09/25 | ||
| High | 39.77 on 03/28/25 | 36.38 on 03/13/25 | 46.50 on 02/06/25 | ||
| 6-Month | |||||
| %Chg | +1.30% since 10/29/24 | -27.84% since 10/29/24 | -27.90% since 10/29/24 | ||
| Low | 23.82 on 01/15/25 | 21.51 on 04/09/25 | 29.59 on 04/09/25 | ||
| High | 39.77 on 03/28/25 | 56.00 on 11/13/24 | 53.47 on 11/06/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 3,571,451 | 3,751,215 | 3,566,056 | ||
| Shares Outstanding, K | 110,128 | 120,212 | 93,893 | ||
| Annual Sales | 398,990,000 | 10,900,000 | 560,230,000 | ||
| Annual Net Income | -257,100,000 | -322,300,000 | -569,180,000 | ||
| Last Quarter Sales | 109,070,000 | 2,970,000 | 164,880,000 | ||
| Last Quarter Net Income | -81,680,000 | -102,260,000 | -133,390,000 | ||
| 60-Month Beta | 1.09 | 1.01 | 0.61 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.80 on 02/27/25 | -0.80 on 02/27/25 | -1.39 on 02/13/25 | ||
| Latest Earnings Date | 05/08/25 | 05/08/25 | 05/01/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||